Ultralasik - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 205,035 | 223,271 | 228,354 | 296,327 | 292,809 | 280,802 | 288,124 | 311,656 |
| Profit before tax | 87,136 | 107,751 | 102,463 | 118,735 | 120,610 | 114,434 | 97,769 | 132,171 |
| Net profit | 82,857 | 102,403 | 97,332 | 112,841 | 114,031 | 108,750 | 82,146 | 110,911 |
| Equity | 466,199 | 557,662 | 611,234 | 680,315 | 728,706 | 760,876 | 766,443 | 746,074 |
| Liabilities | 4,968 | 11,118 | 9,539 | 7,734 | 25,473 | 27,945 | 34,747 | 26,445 |
| Non-current assets | 56,760 | 46,014 | 34,562 | 130,801 | 248,153 | 234,097 | 205,675 | 172,278 |
| Current assets | 413,271 | 522,073 | 585,822 | 556,931 | 505,327 | 554,654 | 595,515 | 599,402 |
| Total assets | 470,031 | 568,087 | 620,384 | 687,732 | 753,480 | 788,751 | 801,190 | 771,680 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 27,096 | 28,709 | 48,265 |
| Social insurance contributions | - | - | - | - | - | 18,326 | 19,770 | 21,205 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +13.8% | +8.9% | +2.3% | +29.8% | -1.2% | -4.1% | +2.6% | +8.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 17.6% | 18.0% | 15.7% | 16.4% | 15.1% | 13.8% | 10.3% | 14.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 17.8% | 18.4% | 15.9% | 16.6% | 15.6% | 14.3% | 10.7% | 14.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 40.4% | 45.9% | 42.6% | 38.1% | 38.9% | 38.7% | 28.5% | 35.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 42.5% | 48.3% | 44.9% | 40.1% | 41.2% | 40.8% | 33.9% | 42.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 35,658 | 39,989 | 34,253 | 42,332 | 45,048 | 46,800 | 48,021 | 51,943 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ultralasik - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-07-24 | 2025-08-10 | 2.78 |
| 2025-06-17 | 2025-06-29 | 1732.64 |
| 2025-02-18 | 2025-03-09 | 0.64 |
| 2025-01-22 | 2025-02-10 | 0.64 |
| 2024-01-16 | 2024-02-12 | 0.20 |
Ultralasik - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-14 | 2025-07-20 | 1046.99 |
| 2025-01-01 | 2025-01-27 | 0.71 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ultralasik, UAB (company code 300118286) is a Private Limited Liability Company engaged in medical specialists activities. In the latest financial year, 2025, the company generated revenue of €311.7K and net profit of €110.9K, with a profit margin of 35.6%. Revenue increased by 8.2% year on year and by 11.0% over two years. The multi-year trend shows steady top-line growth from €280.8K in 2023 to €288.1K in 2024 and €311.7K in 2025, while net profit moved from €108.8K to €82.1K and then recovered to €110.9K in 2025. At year-end 2025, total assets amounted to €771.7K, equity to €746.1K and liabilities to €26.4K, indicating a very strong equity position with an equity ratio of 96.7% and debt-to-equity of 0.04. Return on equity was 14.9% and return on assets 14.4%, while asset turnover stood at 0.40x. Revenue per employee was €51.9K and profit per employee €18.5K.